Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The association between triglycerides and incident cardiovascular disease: What is “optimal”?

Journal of clinical lipidology(2020)10.1016/j.jacl.2020.04.009Source: DataRank Database

The association between triglycerides and incident cardiovascular disease: What is “optimal”? is a research paper published in Journal of clinical lipidology (2020). On theSindex it has a DataRank of 0. It has been cited 119 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access119 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 5.47)OA: hybridTopics (22)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Eric D. Peterson ORCID,Neha J. Pagidipati ORCID,Hillary Mulder ORCID,Daniel Wojdyla,Sephy Philip

Live enrichment

PubMed:32571728 OpenAlex:https://openalex.org/W3022721765

University of California Institute for Mexico and the United States

Grant: K01HL133416

FWCI

5.47

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttp://www.lipidjournal.com/article/S1933287420300799/pdf

publisherhttp://www.lipidjournal.com/article/S1933287420300799/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1933287420300799?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1933287420300799?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jacl.2020.04.009

Fields of Study

Diabetes, Cardiovascular Risks, and LipoproteinsLipoproteins and Cardiovascular HealthAdipokines, Inflammation, and Metabolic Diseases

MeSH Terms

AgedCardiovascular DiseasesFemaleHumansCholesterol, HDLCholesterol, LDLMaleMiddle AgedRisk FactorsTriglycerides

Keywords

MedicineInternal medicineFramingham Risk ScoreMyocardial infarctionStroke (engine)DiseaseConfoundingCholesterolCardiology

Sustainable Development Goals

SDG 0: Gender equality

Related Papers (6)

Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

N/A

14.2DataRank · unranked

Journal of the American College of Cardiology(2020)

co-cited

10.1016/j.jacc.2020.11.010

Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study

N/A

0.917DataRank · unranked

European Heart Journal(2021)

co-cited

10.1093/eurheartj/ehab432

A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk

N/A

0.725DataRank · unranked

Nature Medicine(2024)

co-cited

10.1038/s41591-023-02793-8

Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial

N/A

0.510DataRank · unranked

European Heart Journal(2024)

co-cited

10.1093/eurheartj/ehad889

Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low‐Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE‐IT Randomized Trial

N/A

0.450DataRank · unranked

Journal of the American Heart Association(2025)

co-cited

10.1161/jaha.124.038656

Design and rationale of the CORE-TIMI 72a and CORE2-TIMI 72b trials of olezarsen in patients with severe hypertriglyceridemia

N/A

0.408DataRank · unranked

American Heart Journal(2025)

co-cited

10.1016/j.ahj.2025.03.003